Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03181269 · ClinicalTrials.gov registry record · NA
Human Milk and Infant Intestinal Microbiome Study
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03181269: Completed NA study, sponsored by University of Virginia.
NCT03181269 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03181269, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study will explore the effects of skin-to-skin contact (SSC) between mothers and their babies on the infant intestinal microbiome, the maternal skin microbiome and the breast milk microbiome. This will be accomplished by administering an intervention education session to one group and a placebo education session to the second group in order to influence the magnitude of total SSC defined by the frequency and duration of contact time between the two groups.
Primary Outcome
Self-reported magnitude of maternal-infant skin-to-skin contact
Interventions
- OTHER Intervention education
- OTHER Placebo Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-07-27 |
| Est. Completion | 2018-12-20 |
| Phase | NA |
What the finished NCT03181269 record still lists
NCT03181269 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Intervention education is the first listed.
NCT03181269 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03181269 about?
NCT03181269 is a clinical study titled "Human Milk and Infant Intestinal Microbiome Study". This study will explore the effects of skin-to-skin contact (SSC) between mothers and their babies on the infant intestinal microbiome, the maternal skin microbiome and the breast milk microbiome. This will be accomplished by administering an intervention education session to one group and a placebo...
What is the current status of trial NCT03181269?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2017-07-27. Estimated completion is 2018-12-20.
What interventions are being tested in trial NCT03181269?
The interventions under investigation include: Intervention education (OTHER), Placebo Education (OTHER).
Who is sponsoring clinical trial NCT03181269?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03181269's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI